Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valacyclovir for Suppression of HSV and HIV Shedding in Co-infected Persons
NCT00465205Phase 3Completed
- Sponsor
- University of Washington
- Start
- Jan 2005
- Primary completion
- Dec 2005
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of valaciclovir in herpes simplex (HSV), sponsored by University of Washington. Started Jan 2005; status: completed.
02
Drugs
valaciclovir
03
Conditions
herpes simplex (HSV)
Beyond the preview
Go deeper on NCT00465205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00465205.